We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.9%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$113B
AUM Growth
+$3.29B
(+3%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
17.16%
Holding
4,363
New
403
Increased
1,677
Reduced
1,774
Closed
295
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$603M |
| 2 |
Entergy
ETR
|
+$403M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$296M |
| 5 |
CELG
Celgene Corp
CELG
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.67B |
| 2 |
AABA
Altaba Inc
AABA
|
+$373M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$232M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$229M |
| 5 |
IBM
IBM
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.95% |
| 2 | Healthcare | 10.9% |
| 3 | Financials | 9.6% |
| 4 | Consumer Discretionary | 6.43% |
| 5 | Industrials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
e.l.f. Beauty
ELF
$4.77B
| $176K | ﹤0.01% |
12,539
-2,327
| -16% | -$28.2K |
|
3752
Five Point Holdings
FPH
$387M
| $176K | ﹤0.01% |
23,405
-10,793
| -32% | -$85.7K |
|
3753
Spok Holdings
SPOK
$229M
| $176K | ﹤0.01% |
11,698
-524
| -4% | -$7.78K |
|
|
FRBK
3754
DELISTED
Republic First Bancorp Inc
FRBK
| $176K | ﹤0.01% |
35,816
-2,020
| -5% | -$10.3K |
|
|
ICOL
3755
DELISTED
iShares MSCI Colombia ETF
ICOL
| $176K | ﹤0.01% |
13,300
| – | – |
|
3756
Senseonics Holdings Inc
SENS
$254M
| $175K | ﹤0.01% |
4,285
+376
| +10% | +$15.9K |
|
3757
Lifecore Biomedical
LFCR
$162M
| $173K | ﹤0.01% |
18,515
+873
| +5% | +$8.81K |
|
3758
Village Farms International
VFF
$239M
| $173K | ﹤0.01% |
+15,097
| New | +$191K |
|
3759
Greenlight Captial
GLRE
$579M
| $172K | ﹤0.01% |
20,258
-1,563
| -7% | -$16.1K |
|
3760
Lexicon Pharmaceuticals
LXRX
$1.03B
| $171K | ﹤0.01% |
27,289
-2,510
| -8% | -$15K |
|
|
SPNS
3761
DELISTED
Sapiens International
SPNS
| $171K | ﹤0.01% |
+10,289
| New | +$160K |
|
3762
SFL Corp
SFL
$1.61B
| $166K | ﹤0.01% |
13,248
-10,752
| -45% | -$136K |
|
|
CCXI
3763
DELISTED
ChemoCentryx, Inc.
CCXI
| $166K | ﹤0.01% |
17,832
+4,779
| +37% | +$55.3K |
|
3764
PUT
Green Plains
GPRE
$1.15B
| $165K | ﹤0.01% |
+15,300
| New | +$227K |
|
|
HAPN
3765
PUT
Happen Inc
HAPN
$2.14B
| $164K | ﹤0.01% |
10,000
| – | – |
|
|
GHL
3766
DELISTED
Greenhill & Co., Inc.
GHL
| $162K | ﹤0.01% |
11,907
-7,146
| -38% | -$131K |
|
3767
America Movil
AMX
$74.6B
| $160K | ﹤0.01% |
11,015
-85,402
| -89% | -$1.26M |
|
3768
Aurinia Pharmaceuticals
AUPH
$1.95B
| $160K | ﹤0.01% |
24,303
+4,194
| +21% | +$26.7K |
|
3769
Abeona Therapeutics
ABEO
$355M
| $157K | ﹤0.01% |
1,318
+201
| +18% | +$33.7K |
|
|
ONIT
3770
Onity Group
ONIT
$342M
| $156K | ﹤0.01% |
5,036
-179
| -3% | -$4.78K |
|
3771
BlackRock MuniYield New York Quality Fund
MYN
$376M
| $155K | ﹤0.01% |
12,200
| – | – |
|
|
AGNT
3772
AGNT Inc
AGNT
$629M
| $151K | ﹤0.01% |
+27,042
| New | +$143K |
|
|
GNC
3773
DELISTED
GNC Holdings, Inc.
GNC
| $151K | ﹤0.01% |
100,829
+43,518
| +76% | +$82.5K |
|
|
AVDL
3774
DELISTED
Avadel Pharmaceuticals
AVDL
| $150K | ﹤0.01% |
51,772
+33,171
| +178% | +$57K |
|
|
STKL
3775
DELISTED
SunOpta
STKL
| $148K | ﹤0.01% |
45,100
-74,900
| -62% | -$276K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2019 Portfolio in Review
As of Q2 2019, Credit Suisse held 4,363 positions worth $113B, up 3% from $110B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse's Q2 2019 filing shows 403 new, 1,677 increased, 1,774 reduced and 295 closed positions. Its largest new stake was Alcon: 10,270,934 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.67B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
- Credit Suisse's largest Q2 2019 buy was Alcon: 10,270,934 shares worth $637M.
- Credit Suisse added most to Entergy in Q2 2019, an estimated $403M increase.
- Credit Suisse's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.67B.
- Credit Suisse fully exited iShares Core MSCI Total International Stock ETF in Q2 2019, selling an estimated $232M.
- Credit Suisse's ten largest holdings make up 17% of its $113B portfolio in Q2 2019.
- Credit Suisse opened 403 new positions and closed 295 in Q2 2019.
- Credit Suisse's portfolio value rose 3% quarter-over-quarter to $113B.
Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.